Fig. 5. Overexpression of FosB/ΔFosB by chronic L-DOPA is reduced in the 6-OHDA-lesioned striatum of PA-5HT-treated mice. Protein levels of FosB and ΔFosB were evaluated by western blots (A). ΔFosB (B) and FosB (C) levels in the 6-OHDA lesioned versus unlesioned striata (n=8-9). One-way ANOVA followed by a Tukey-Kramer post hoc test.*p<0.05 and **p<0.01. Data are presented as the mean±SEM. L-DOPA: L-3,4-dihydroxyphenylalanine; 6-OHDA: 6-hydroxydopamine.
© Exp Neurobiol